• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210^<bcr/abl>

Research Project

Project/Area Number 11670981
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionUniversity of Tokyo

Principal Investigator

KUROKAWA Mineo  Tokyo University Facuulty of medicin Assistant Professor, 医学部・附属病院, 助手 (80312320)

Co-Investigator(Kenkyū-buntansha) TAKAHASHI Tokiharu  Tokyo University Facuulty of medicin Assistant Professor, 医学部・附属病院, 助手 (30313125)
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥4,100,000 (Direct Cost: ¥4,100,000)
Fiscal Year 2000: ¥1,500,000 (Direct Cost: ¥1,500,000)
Fiscal Year 1999: ¥2,600,000 (Direct Cost: ¥2,600,000)
Keywordsp210^<bcr / abl> / transgenic mice / tec promoter / ALL / CML / メタロチオネインプロモーター
Research Abstract

The Philadelphia (Ph) chromosome can be detected in chronic myelogenous leukemia (CML) and a significant number of acute lymphoblastic leukemia (ALL) cases. Generation of p210^<bcr/abl>, a chimeric protein with enhanced kinase activity, is thought to be involved in the pathogenesis of these diseases. To elucidate the biological properties of p210^<bcr/abl> and to create an animal model for human Ph^1-positive leukemias, we generated transgenic mice expressing p210^<bcr/abl> driven by the promoter of the tec gene, a cytoplasmic tyrosine-kinase preferentially expressed in the hematopoietic lineage. The founder mice showed excessive proliferation of lymphoblasts shortly after birth and were diagnosed as suffering from ALL based on surface marker and Southern blot analyses. Expression and enhanced kinase activity of the p210^<bcr/abl> transgene product were detected in the leukemic tissues. In contrast, transgenic progeny exhibited marked granulocyte hyperplasia with thrombocytosis after a long latent period and developed myeloproliferative disorders (MPDs) closely resembling human CML.Expression of p210^<bcr/abl> mRNA in the proliferating granulocytes was detected by RT-PCR.In particular, one MPD mouse showed remarkable proliferation of blast cells in the lung, which might represent an extramedullar blast crisis. The results demonstrate that the expression of p210^<bcr/abl> in hematopoietic progenitor cells in transgenic mice can contribute to two clinically distinct hematopoietic malignancies, CML and ALL, indicating that this transgenic system provides a novel transgenic model for human Ph^1-positive leukemias.

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (20 results)

All Other

All Publications (20 results)

  • [Publications] Maki K,Mitani K,Yamagata T,Kurokawa M,Kanda Y,Yazaki Y, and Hirai H.: "Transcriptional inhibition of p53 by the MLL/MEN chimeric protein found in myeloid leukemia."Blood. 93. 3216-3224 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hirai H,Ogawa S,Kurokawa M,Yazaki Y, and Mitani K: "Molecular characterization of the genomic breakpoints in a case of t(3 ; 21)(q26 ; q22)."Genes,Chromosomes, and Cancer. 26. 92-96 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kurokawa M.Mitani K,Yamagata T,Takahashi T,Izutsu K,Ogawa S,Moriguchi T,Nishida E,Yazaki Y. and Hirai H.: "The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death."The EMBO Journal. 19. 2958-2968 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Imai Y,Kurokawa M.Izutsu K,Hangaishi A,Takeuchi K,Maki K,Ogawa S,Chiba S,Mitani K, and Hirai H: "Mutations of the AML1 gene in patients with myelodysplastic syndrome and their functional implications in leukemogenesis."Blood. 96. 3154-3160 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Imai Y,Kurokawa M,Izutsu K,Hangaishi A,Ogawa S,Chiba S,Mitani K, and Hirai H.: "Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis."Oncogene . 20. 88-96 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Izutsu K,Kurokawa M,Imai Y,Maki K,Mitani K, and Hirai H.: "The corepressor CtBP interacts with Evi-1 to repress TGF-β signaling."Blood. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Maki K, Mitani K, Yamagata T, Kurokawa M, Kanda Y, Yazaki Y, and Hirai H.: "Transcriptional inhibition of p53 by the MLL/MEN chimeric protein found in myeloid leukemia."Blood. 93. 3216-3224 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hirai H, Ogawa S, Kurokawa M, Yazaki Y, and Mitani K.: "Molecular characterization of the genomic breakpoints in a case of t(3 ; 21) (q26 ; q22)."Genes, Chromosomes, and Cancer. 26. 92-96 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kurokawa M, Mitani K, Yamagata T, Takahashi T, Izutsu K, Ogawa S, Moriguchi T, Nishida E, Yazaki Y, and Hirai H.: "The Evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death."The EMBO Journal. 19. 2958-2968 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Imai Y, Kurokawa M, Izutsu K, Hangaishi A, Takeuchi K, Maki K, Ogawa S, Chiba S, Mitani K, and Hirai H.: "Mutations of the AML1 gene in patients with myelodysplastic syndrome and their functional implications in leukemogenesis."Blood. 96(9). 3154-3160 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Imai Y, Kurokawa M, Izutsu K, Hangaishi A, Ogawa S, Chiba S, Mitani K, and Hirai H.: "Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis."Oncogene. 20. 88-96 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Izutsu K, Kurokawa M, Imai Y, Maki K, Mitani K, and Hirai H.: "The corepressor CtBP interacts with Evi-1 to repress TGF-β signaling."Blood. in press.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Maki K,Mitani K,Yamagata T,Kurokawa M,Kanda Y,Yazaki Y, and Hirai H.: "Transcriptional inhibition of p53 by the MLL/MEN chimeric protein found in myeloid leukemia."Blood. 93. 3216-3224 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Hirai H,Ogawa S,Kurokawa M,Yazaki Y,and Mitani K: "Molecular characterization of the genomic breakpoints in a case of t(3;21)(q26;q22).s"Genes,Chromosomes, and Cancer. 26. 92-96 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Kurokawa M,Mitani K,Yamagata T,Takahashi T,Izutsu K,Ogawa S,Moriguchi T.Nishida E,Yazaki Y,and Hirai H: "The Evi-l oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death."The EMBO Journal. 19. 2958-2968 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Imai Y,Kurokawa M,Izutsu K,Hangaishi A,Takeuchi K,Maki K,Ogawa S,Chiba S,Mitani K and Himi H: "Mutations of the AMLl gene in patients with myelodysplastic syndrome and their functional implications in leukemogenesis."Blood. 96. 3154-3160 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Imai Y,Kurokawa M,Izutsu K,Hangaishi A,Ogawa S,Chiba S,Mitani K,and Hirai H.: "Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis."Oncogene. 20. 88-96 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Izutsu K,Kurokawa M,Imai Y,Maki K,Mitani K,and Hirai H.: "The corepressor CtBP interacts with Evi-1 to repress TGF-β signaling."Blood. (in press).

    • Related Report
      2000 Annual Research Report
  • [Publications] Maki K, Mitani K, Yamagata T, Kurokawa M, Kanda Y, Yazake Y, and Hirai H.: "Transcriptional inhibition of p53 by the MLL/MEN chimeric protein found in myeloid leukemia"Blood. 93. 3216-3224 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Hirai H, Ogawa S, Kurokawa M, Yazaki Y, and Mitani K.: "Molecular characterization of the genomic brekpoints in a case of t(3;21)(q26;q22)"Genes, Chromosomes, and Cancer. 26. 92-99 (1999)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi